Recent research is showing that some of these weight loss drugs GLP-1 receptor agonists, which include Ozempic and things like Wegovy may decrease cancer mortality. The people who are most obese benefit the most. The effects were big. Colon cancer patients taking GLP-1 drugs (Ozempic, Wegovy, Mounjaro) were less than half as likely to die within 5 years. This new study suggests GLP-1 drugs might specifically target obesity-driven inflammatory and metabolic pathways known to accelerate colon canc